Compound Detail
CHEMBL5990800
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5990800 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZWDPQPKCKRVHBW-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
490.0
MW (Da)
4.70
ALogP
8
HBA
3
HBD
119.2
PSA (Ų)
0.37
QED
0
Ro5 Violations
10
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 8.68
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Insulin receptor CHEMBL1981 | IC50 | 8.68 | 8.68 | 2.1 | 1 |
| ALK tyrosine kinase receptor CHEMBL4247 | IC50 | 8.51 | 8.51 | 3.1 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Insulin receptor | IC50 | = | 2.1 | nM | 8.68 | Inhibition of ALK IR Anaplastic Lymphoma Kinase Activity: To measure the activit... | - |
| ALK tyrosine kinase receptor | IC50 | = | 3.1 | nM | 8.51 | Inhibition of ALK WT Anaplastic Lymphoma Kinase Activity: The following experime... | - |
Data from ChEMBL 36 via Core Engine